Skip to content

Myopia Control With Simultaneous Vision Approach

Control of Myopia Progression in Myopic Children Using Simultaneous Vision Approach

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00919334
Enrollment
100
Registered
2009-06-12
Start date
2007-07-31
Completion date
2011-06-30
Last updated
2014-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Keywords

Myopia progression, Myopia control, Simultaneous vision, Myopic defocus

Brief summary

To determine if the 'Defocus Incorporated Soft Contact' (DISC) lens slows myopia progression in Hong Kong schoolchildren using simultaneous vision approach.

Detailed description

The investigators hypothesize that the natural process of emmetropization in human is regulated by the equilibrium between the opposite hyperopic and myopic defocus. A sharp focus of retinal image (foveal fixation) is fundamental for co-ordination of the equilibrium. The DISC lens is a custom-made multi-zone bifocal soft contact lens which is based on simultaneously provides clear vision and defocus at all viewing distances. It comprises of correcting zones for correcting distant prescription(correction of refractive error, and defocusing zones to incorporate constant myopic defocus for slowing down myopia progression.

Interventions

DEVICEDefocus Incorporated Soft Contact (DISC) lens

Use of simultaneous vision bifocal soft contact lenses with myopic defocus to control the progression of myopia

Sponsors

The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
8 Years to 13 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 8-13 years * Myopia (SE) between -1D to -5D * Astigmatism less than or equal to -1D * Anisometropia: less than or equal to 1.25D * aided VA (monocular): 0.00 log MAR or better * willingness to wear contact lens constantly * availability for follow-up for at least 2.5 years * parents' understanding and acceptance * willing to provide refractive status of grandparents

Exclusion criteria

* Severe ocular or systemic allergies * Taking any medication that might have an impact on contact lens wear or that might influence the outcome of the clinical trial * Ocular or systemic condition that might affect refractive development * Strabismus at distance or near * Prior use of bifocal or progressive lenses * Prior use of rigid gas permeable lenses and Ortho-K lenses

Design outcomes

Primary

MeasureTime frameDescription
The changes of cycloplegic refractive errorsevery 6 months for 2 yearsRefractive error was measured using Shin-Nippon NVision-K 5001 autorefractor The changes of cycloplegic objective refractive errors between the treatment and the control were compared.

Secondary

MeasureTime frameDescription
The changes of axial lengthevery 6 months for 2 yearsAxial length was measured after cycloplegia using IOL Master

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026